Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit

Anaesthesia

Volumn 54, Issue 12, 1999, Pages 1136-1142

  Venn, R M ^a   Bradshaw, C J ^a   Spencer, R ^b   Brealey, D ^c   Caudwell, E ^c   Naughton, C ^d   Vedio, A ^d   Singer, M ^c   Feneck, R ^d   Treacher, D ^d   Willatts, S M ^b   Grounds, R M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Dexmedetomidine, sedation; Intensive care, postoperative

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; MORPHINE; SEDATIVE AGENT;

ADULT; AGED; ANALGESIA; ANGINA PECTORIS; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL SURGERY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SEDATION; STROKE; TACHYCARDIA; UNITED KINGDOM; VOMITING;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; CARDIOVASCULAR DISEASES; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; MALE; MIDAZOLAM; MIDDLE AGED; MORPHINE; POSTOPERATIVE CARE;

EID: 0032705173     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1999.01114.x     Document Type: Article

References (11)

1. Beattie WS, Buckley DN, Forrest JB. Epidural morphine reduces the risk of postoperative myocardial ischaemia in patients with cardiac risk factors. Canadian Journal of Anaesthesia 1993; 40: 532-41.
2. Prielipp RC, Coursin DB, Wood KE, Murray MJ. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Critical Care Clinics 1995; 11: 983-1003.
3. Hayashi Y, Maze M. Alpha-2 adrenoceptor agonists and anaesthesia. British Journal of Anaesthesia 1993; 71: 108-18.
4. Belleville JP, Ward DS, Bloor BC, et al. Ventilatory effects of dexmedetomidine in humans. Anesthesiology 1990; 73: A1167.
5. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxolone-alphadolone. British Medical Journal 1974; II: 656-9.
6. Bloor BC, Ward DS, Belleville JP, Maze M. Sedative and hemodynamic effects of dexmedetomidine in humans. Anesthesiology 1990; 73: A411.
7. Dyck JB, Maze M, Shafer SL. The pharmacokinetics of dexmedetomidine in adults. Anesthesiohgy 1991; 75: A310.
8. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D. Effects ot dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies. Anesthesia and Analgesia 1991; 73: 204-8.
9. Low JM. Haemodynamic monitoring. In: Oh TE, ed. Intensive Care Manual, 3rd edn. London: Butterworths, 1991: 583.
10. Conti J, Smith D. Haemodynamic responses to extubation after cardiac surgery with and without continued sedation. British Journal of Anaesthesia 1998; 80: 834-6.
11. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine an alpha 2 adrenoceptor agonist, reduces anaesthetic requirements for patients undergoing minor gynaecological surgery. Anesthesiology 1990; 73: 230-5.